South Africa Wound Care Management Industry Investment Opportunities, Analysis and Forecasts to 2012

Published by: Global Markets Direct

Published: May. 16, 2008 - 308 Pages

Table of Contents

1 Table Of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

3 Healthcare Sector Review

4 Wound Care Manegement in South Africa

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in South Africa

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Hemostats Overall Volume (2000-2012)

5.2.3 Tissue Sealants Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2005-2006)

5.5 Wound Closure Devices Company Share (2005-2006)

6 Ostomy in South Africa

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in South Africa

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in South Africa

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2005-2006)

8.5 Traditional Wound Management Company Share (2005-2006)

9 Compression Therapy in South Africa

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Overall Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2005-2006)

9.5 Compression Therapy Company Share (2005-2006)

10 Baxter International Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 BioScience

10.2.2 Medication Delivery

10.2.3 Renal

10.2.4 Products

10.2.5 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Baxter International Inc. Strengths

10.4.2 Baxter International Inc. Weaknesses

10.4.3 Baxter International Inc. Opportunities

10.4.4 Baxter International Inc. Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Baiyunshan And Baxter Form A Joint Venture In China

10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

10.7.5 Innovata signs a license agreement with Baxter International

10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International

10.7.7 Gambro Signs An Agreement With Baxter

10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement

10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

10.7.10 Baxter International And Kaketsuken Enter Into Agreement

10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

10.8 Recent Developments

10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

10.8.2 Dec 18, 2007: Baxter Elects CFO

10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

10.8.4 Aug 01, 2007: Baxter Elects New Board Director

10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend

10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

10.9 Baxter International Inc. Pipeline Products

10.9.1 Next-Generation Home Hemodialysis Machine

11 Covidien Ltd./Tyco Healthcare Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Imaging Solutions

11.2.2 Medical Devices

11.2.3 Medical Supplies

11.2.4 Pharmaceutical Products

11.2.5 Retail Products

11.2.6 Products

11.2.7 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 Covidien Ltd./Tyco Healthcare Strengths

11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses

11.4.3 Covidien Ltd./Tyco Healthcare Opportunities

11.4.4 Covidien Ltd./Tyco Healthcare Threats

11.5 Financial and Operational Review

11.5.1 Financial Statements

11.5.2 Financial Ratios

11.6 Locations And Subsidiaries

11.7 Other Locations & Subsidiaries

11.8 Financial Deals Landscape

11.8.1 Covidien Signs An Agreement With Allergan

11.8.2 Covidien Acquires Scandius Biomedical

11.8.3 Covidien International Finance Completes Private Placement Of $2,750 Million

11.8.4 Covidien And BioSynthema Enter Into Licensing Agreement

11.8.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien

11.8.6 Covidien To Sell European Incontinence Business

11.8.7 Covidien To Acquire Tissue Science Laboratories

11.9 Recent Developments

11.9.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007

11.9.2 Mar 18, 2008: Covidien Declares Quarterly Dividend

11.9.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case

11.9.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results

11.9.5 Jan 15, 2008: Covidien Declares Quarterly Dividend

11.9.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results

11.9.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results

11.9.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent

11.9.9 Sep 28, 2007: Covidien Declares Quarterly Dividend

11.9.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results

11.10 Covidien Ltd./Tyco Healthcare Pipeline Products

11.10.1 PleuraSeal Lung Sealant System

11.10.2 Sandman Intro CPAP Device

12 3M Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Consumer and Office

12.2.2 Display and Graphics

12.2.3 Electro and Communications

12.2.4 Health Care

12.2.5 Industrial and Transportation

12.2.6 Safety, Security and Protection Services

12.2.7 Products

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 3M Company Strengths

3M Company Weaknesses

3M Company Opportunities

3M Company Threats

12.5 Financial and Operational Review

12.6 Locations And Subsidiaries

12.6.1 Other Locations & Subsidiaries

12.7 Financial Deals Landscape

12.7.1 3M Canada Acquires Les Entreprises Solumed

12.7.2 3M Acquires Bondo

12.7.3 3M Acquires Lingualcare

12.7.4 3M Acquires Abzil Industria E Comercio

12.7.5 3M Acquires Neo Plast

12.7.6 3M Acquires Assets Of DMS Chile

12.7.7 3M Acquires Business Of Innovative Paper Technologies

12.7.8 3M Acquires Powell

12.7.9 Gen-Probe Signs An Agreement With 3M Company

12.7.10 3M Acquires Acolyte Biomedica

12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp.

12.7.12 3M Sells Its Pharmaceutical Business To Meda AB

12.7.13 3M Acquires SoftMed Systems

12.7.14 3M Sells its Pharmaceuticals Business to Graceway

12.7.15 Gen-Probe Signs An Agreement With 3M

12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital

12.7.17 3M Acquires Biotrace International

12.7.18 Ekahau Secures $16 Million In Additional Funding

12.7.19 3M Acquires Brontes Technologies

12.7.20 3M acquires Nylonge Corp

12.7.21 3M Signs An Agreement With ClozeX Medical

12.7.22 3M Acquires OMNII Oral Pharmaceuticals

12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway

12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB

12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital

12.7.26 3M Acquires Accuspray Application Technologies Inc.

12.7.27 3M to acquire Rochford Thompson Equipment

12.7.28 3M To Acquire Aearo Technologies From Permira

12.7.29 Permira To Sell Aearo Technologies To 3M

12.8 Recent Developments

12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses

12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State

12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia

12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia

12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year

12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend

12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery

12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend

12.8.9 May 08, 2007: 3M Declares Quarterly Dividend

12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests

13 Ethicon, Inc. Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Products

13.3 Locations And Subsidiaries

13.4 Other Locations & Subsidiaries

13.5 Financial Deals Landscape

13.5.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON

13.5.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON

13.5.3 ETHICON Acquires Vascular Control Systems

13.5.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON

14 Smith & Nephew Plc Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Advanced Wound Management

14.2.2 Endoscopy

14.2.3 Reconstruction

14.2.4 Trauma and Clinical Therapies

14.2.5 Products

14.2.6 History

14.3 Value Chain Analysis

14.3.1 Manufacturing

14.3.2 Product Development

14.3.3 Sales and Marketing

14.4 SWOT Analysis

14.4.1 Smith & Nephew Plc Strengths

14.4.2 Smith & Nephew Plc Weaknesses

14.4.3 Smith & Nephew Plc Opportunities

14.4.4 Smith & Nephew Plc Threats

14.5 Financial and Operational Review

14.6 Locations And Subsidiaries

14.7 Financial Deals Landscape

14.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

14.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

14.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

14.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

14.7.5 Smith & Nephew Acquires BlueSky Medical Group

14.7.6 Smith & Nephew Enters Into An Agreement With Covalon

14.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

14.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

14.7.9 Smith & Nephew Acquires Osteobiologics

14.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

14.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

14.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

14.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

14.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

14.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

14.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

14.7.17 Smith & Nephew Terminates Acquisition Of Biomet

14.8 Recent Developments

14.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

14.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

14.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

14.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

14.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails

14.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

14.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

14.9 Smith & Nephew Plc Pipeline Products

14.9.1 R3 Modular resurfacing Acetabular system

14.9.2 R3 Ceramic-on-ceramic Acetabular System

15 Regulation System

15.1 Medical Equipment Regulation System

15.2 Regulation of Electromagnetic Medical Devices

15.3 Future Outlook

16 Pricing and Reimbursement

16.1 Reimbursement

16.2 Pricing

17 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List of Tables

Table 1: Wound Care Management, South Africa, Overall Revenues ($ mn), 2000-2012

Table 2: Wound Care Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 3: Wound Care Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 4: Wound Care Management, South Africa, Category Revenues ($ mn), 2000-2012

Table 5: Wound Care Management, South Africa, Category Revenues ($ mn), Historic, 2000-2007

Table 6: Wound Care Management, South Africa, Category Revenues ($ mn), Forecast, 2007-2012

Table 7: Wound Care Management, South Africa, Category Volume (Units), 2000-2012

Table 8: Wound Care Management, South Africa, Category Volume (Units), Historic, 2000-2007

Table 9: Wound Care Management, South Africa, Category Volume (Units), Forecast, 2007-2012

Table 10: Wound Care Management, South Africa, Overall Company Share by Revenue ($ mn), 2005-2006

Table 11: Wound Closure Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 12: Wound Closure Devices, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 13: Wound Closure Devices, South Africa, Revenue by Segment ($ mn), Historic, 2000-2007

Table 14: Wound Closure Devices, South Africa, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 15: Skin Closure Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 16: Skin Closure Devices, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 17: Hemostats, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 18: Hemostats, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 19: Tissue Sealants, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 20: Tissue Sealants, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 21: Wound Closure Devices, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 22: Wound Closure Devices, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 23: Skin Closure Devices, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 24: Skin Closure Devices, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 25: Hemostats, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 26: Hemostats, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 27: Tissue Sealants, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 28: Tissue Sealants, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 29: Hemostats, South Africa, Average Price ($), Historic, 2000-2007

Table 30: Hemostats, South Africa, Average Price ($), Forecast, 2007-2012

Table 31: Tissue Sealants, South Africa, Average Price ($), Historic, 2000-2007

Table 32: Tissue Sealants, South Africa, Average Price ($), Forecast, 2007-2012

Table 33: Skin Closure Devices, South Africa, Average Price ($), Historic, 2000-2007

Table 34: Skin Closure Devices, South Africa, Average Price ($), Forecast, 2007-2012

Table 35: Wound Closure Devices, South Africa, Distribution Share by Revenue ($ mn), 2005-2006

Table 36: Wound Closure Devices, South Africa, Company Share by Revenue ($ mn), 2005-2006

Table 37: Ostomy, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 38: Ostomy, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 39: Ostomy, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 40: Ostomy, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 41: Ostomy, South Africa, Average Price ($), Historic, 2000-2007

Table 42: Ostomy, South Africa, Average Price ($), Forecast, 2007-2012

Table 43: Ostomy, South Africa, Distribution Share by Revenue ($ mn), 2005-2006

Table 44: Ostomy, South Africa, Company Share by Revenue ($ mn), 2005-2006

Table 45: Advanced Wound Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 46: Advanced Wound Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 47: Advanced Wound Management, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 48: Advanced Wound Management, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 49: Advanced Wound Management, South Africa, Average Price ($), Historic, 2000-2007

Table 50: Advanced Wound Management, South Africa, Average Price ($), Forecast, 2007-2012

Table 51: Advanced Wound Management, South Africa, Distribution Share by Revenue ($ mn), 2005-2006

Table 52: Advanced Wound Management, South Africa, Company Share by Revenue ($ mn), 2005-2006

Table 53: Traditional Wound Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 54: Traditional Wound Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 55: Traditional Wound Management, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 56: Traditional Wound Management, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 57: Traditional Wound Management, South Africa, Average Price ($), Historic, 2000-2007

Table 58: Traditional Wound Management, South Africa, Average Price ($), Forecast, 2007-2012

Table 59: Traditional Wound Management, South Africa, Distribution Share by Revenue ($ mn), 2005-2006

Table 60: Traditional Wound Management, South Africa, Company Share by Revenue ($ mn), 2005-2006

Table 61: Compression Therapy, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Table 62: Compression Therapy, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Table 63: Compression Therapy, South Africa, Overall Volume (Units), Historic, 2000-2007

Table 64: Compression Therapy, South Africa, Overall Volume (Units), Forecast, 2007-2012

Table 65: Compression Therapy, South Africa, Average Price ($), Historic, 2000-2007

Table 66: Compression Therapy, South Africa, Average Price ($), Forecast, 2007-2012

Table 67: Compression Therapy, South Africa, Distribution Share by Revenue ($ mn), 2005-2006

Table 68: Compression Therapy, South Africa, Company Share by Revenue ($ mn), 2005-2006

Table 69: Baxter International Inc., SWOT Analysis, 2006

Table 70: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 71: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 72: Baxter International Inc., Other Locations

Table 73: Baxter International Inc., Subsidiaries

Table 74: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007

Table 75: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007

Table 76: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007

Table 77: Covidien Ltd./Tyco Healthcare, Other Locations

Table 78: Covidien Ltd./Tyco Healthcare, Subsidiaries

Table 79: 3M Company, SWOT Analysis, 2006

Table 80: 3M Company, Financial Statements, USD Million, 2002-2006

Table 81: 3M Company, Financial and Operational Overview, USD Million, 2002-2006

Table 82: 3M Company, Subsidiaries

Table 83: Ethicon, Inc., Other Locations

Table 84: Ethicon, Inc., Subsidiaries

Table 85: Smith & Nephew Plc, SWOT Analysis, 2006

Table 86: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006

Table 87: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006

Table 88: Smith & Nephew Plc, Other Locations

Table 89: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.2 List of Figures

Figure 1: Wound Care Management, South Africa, Overall Revenues ($ mn), 2000-2012

Figure 2: Wound Care Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 3: Wound Care Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 4: Wound Care Management, South Africa, Category Revenues ($ mn), 2000-2012

Figure 5: Wound Care Management, South Africa, Category Revenues ($ mn), Historic, 2000-2007

Figure 6: Wound Care Management, South Africa, Category Revenues ($ mn), Forecast, 2007-2012

Figure 7: Wound Care Management, South Africa, Category Volume (Units), 2000-2012

Figure 8: Wound Care Management, South Africa, Category Volume (Units), Historic, 2000-2007

Figure 9: Wound Care Management, South Africa, Category Volume (Units), Forecast, 2007-2012

Figure 10: Wound Care Management, South Africa, Overall Company Share (%), 2006

Figure 11: Wound Closure Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 12: Wound Closure Devices, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 13: Wound Closure Devices, South Africa, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 14: Wound Closure Devices, South Africa, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 15: Skin Closure Devices, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 16: Skin Closure Devices, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 17: Hemostats, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 18: Hemostats, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 19: Tissue Sealants, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 20: Tissue Sealants, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 21: Wound Closure Devices, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 22: Wound Closure Devices, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 23: Skin Closure Devices, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 24: Skin Closure Devices, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 25: Hemostats, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 26: Hemostats, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 27: Tissue Sealants, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 28: Tissue Sealants, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 29: Hemostats, South Africa, Average Price ($), Historic, 2000-2007

Figure 30: Hemostats, South Africa, Average Price ($), Forecast, 2007-2012

Figure 31: Tissue Sealants, South Africa, Average Price ($), Historic, 2000-2007

Figure 32: Tissue Sealants, South Africa, Average Price ($), Forecast, 2007-2012

Figure 33: Skin Closure Devices, South Africa, Average Price ($), Historic, 2000-2007

Figure 34: Skin Closure Devices, South Africa, Average Price ($), Forecast, 2007-2012

Figure 35: Wound Closure Devices, South Africa, Distribution Share (%), 2006

Figure 36: Wound Closure Devices, South Africa, Company Share (%), 2006

Figure 37: Ostomy, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 38: Ostomy, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 39: Ostomy, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 40: Ostomy, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 41: Ostomy, South Africa, Average Price ($), Historic, 2000-2007

Figure 42: Ostomy, South Africa, Average Price ($), Forecast, 2007-2012

Figure 43: Ostomy, South Africa, Company Share (%), 2006

Figure 44: Advanced Wound Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 45: Advanced Wound Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 46: Advanced Wound Management, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 47: Advanced Wound Management, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 48: Advanced Wound Management, South Africa, Average Price ($), Historic, 2000-2007

Figure 49: Advanced Wound Management, South Africa, Average Price ($), Forecast, 2007-2012

Figure 50: Advanced Wound Management, South Africa, Distribution Share (%), 2006

Figure 51: Advanced Wound Management, South Africa, Company Share (%), 2006

Figure 52: Traditional Wound Management, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 53: Traditional Wound Management, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 54: Traditional Wound Management, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 55: Traditional Wound Management, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 56: Traditional Wound Management, South Africa, Average Price ($), Historic, 2000-2007

Figure 57: Traditional Wound Management, South Africa, Average Price ($), Forecast, 2007-2012

Figure 58: Traditional Wound Management, South Africa, Distribution Share (%), 2006

Figure 59: Traditional Wound Management, South Africa, Company Share (%), 2006

Figure 60: Compression Therapy, South Africa, Overall Revenues ($ mn), Historic, 2000-2007

Figure 61: Compression Therapy, South Africa, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 62: Compression Therapy, South Africa, Overall Volume (Units), Historic, 2000-2007

Figure 63: Compression Therapy, South Africa, Overall Volume (Units), Forecast, 2007-2012

Figure 64: Compression Therapy, South Africa, Average Price ($), Historic, 2000-2007

Figure 65: Compression Therapy, South Africa, Average Price ($), Forecast, 2007-2012

Figure 66: Compression Therapy, South Africa, Distribution Share (%), 2006

Figure 67: Compression Therapy, South Africa, Company Share (%), 2006

Figure 68: Baxter International Inc., Value Chain Analysis

Figure 69: Covidien Ltd./Tyco Healthcare, Value Chain Analysis

Figure 70: 3M Company, Value Chain Analysis

Figure 71: Smith & Nephew Plc, Value Chain Analysis

Figure 72: Global Markets Direct Methodology

Abstract

• The report provides wound care management devices information broken down into detailed categories and segments in South Africa.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the wound care management devices market in South Africa.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.